New long-term data for Roche’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)
February 01, 2024 01:03 ET
|
F. Hoffmann-La Roche Ltd
Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry vision Up to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months...
Privia Health to Participate in the J.P. Morgan Healthcare Conference
December 12, 2023 09:00 ET
|
Privia Health Group, Inc.
Privia Health (Nasdaq: PRVA) will present at the J.P. Morgan HC Conference on Monday, January 8, 2024, beginning at 6:45 pm ET / 3:45 pm PT
RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO
December 01, 2023 12:32 ET
|
RetinalGeniX Technologies, Inc.
RETINALGENIX TECHNOLOGIES INC. ANNOUNCES HIRING OF INTERIM CFO
Virender Ahluwalia will serve as Interim Chief Financial Officer
Corza Medical Opens State-of-the-Art Ophthalmology Center of Technology and Innovation, Demonstrating Commitment to Global Eye Care Community
November 30, 2023 08:05 ET
|
Corza Medical Inc.
Corza Medical opens a new Ophthalmology Center of Technology and Innovation in MO to develop next-gen devices for eye treatments and enhance R&D.
SBLA BEAUTY Eye Lift Wand Recognized With “Eye Treatment Product Of The Year ” Award From Beauty Innovation
November 15, 2023 08:00 ET
|
Beauty Innovation Awards
LOS ANGELES, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The 2023 Beauty Innovation Awards today announced that the Eye Lift Wand from SBLA BEAUTY has been selected as “Eye Treatment Product Of The Year” in...
Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Metastatic Uveal Melanoma
November 13, 2023 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided updated data from an ongoing Phase 1 clinical trial of investigational cancer immunotherapy PV-10 (rose bengal...
RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs
November 09, 2023 12:58 ET
|
RetinalGeniX Technologies, Inc.
RetinalGeniX Announces Therapeutic Solutions Being Developed for Dry Age-Related Macular Degeneration
and Alzheimer’s Syndrome.
SAFEchild Awarded $500,000 Grant from SECU Foundation for New Child Advocacy and Resource Center
September 12, 2023 15:03 ET
|
State Employees' Credit Union (SECU)
RALEIGH, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Wake County non-profit SAFEchild was recently awarded a $500,000 grant from SECU Foundation to help expand its programs through the construction of...
NATIONAL VISION ALERT: Bragar Eagel & Squire, P.C. is Investigating National Vision Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
September 12, 2023 02:30 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against National Vision Holdings,...
[Latest] Global Biaxially Oriented Polypropylene (BOPP) Films Market Size/Share Worth USD 47.6 Billion by 2032 at a 5.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate)
September 07, 2023 16:45 ET
|
Custom Market Insights
Austin, TX, USA, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Biaxially Oriented Polypropylene (BOPP) Films Market Size, Trends and Insights...